The split is on the tableas a bargaining chip for Neovasc to be granted an extension on the NASDAQ. If the Company's extension is granted, I doubt the reverse split will be initiated, particularly if they succeed in amending the terms of the remaining 2017 financing ("Event Price Provisions"). I personally think its worth the effort. So, even if a split is voted for, we won't see it unless the "Company is not able to amend such provisions or obtain a waiver of such provisions in connection with its efforts to address the challenges to its capital structure, the Company may elect not to proceed with the reverse stock split." The NASDAQ is important to attract larger institutional investors in the U.S. to bring its products there to market.